title: Re: Francis et al.: The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan (Ophthalmology 2015;122:1173-9).
authors.affiliation: Ophthalmic Plastics, Orbit and Ocular Oncology Services, LV Prasad Eye Institute, Bhubaneswar, Odisha, India. Electronic address: dr.niveditasahoo@gmail.com.
authors.forename: Nibedita
authors.initials: N
authors.lastname: Sahoo
authors.affiliation: Ophthalmic Plastics, Orbit and Ocular Oncology Services, LV Prasad Eye Institute, Bhubaneswar, Odisha, India.
authors.forename: Devjyoti
authors.initials: D
authors.lastname: Tripathy
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D005134:Eye Neoplasms / Q000145:classification*; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage*; D009366:Neoplasm Seeding; D019572:Retinal Neoplasms / Q000145:classification*; D012175:Retinoblastoma / Q000145:classification*; D014822:Vitreous Body / Q000187:drug effects* / Q000473:pathology*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan